Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Author:
- 1 June 2022
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 234, 108031
Abstract
No abstract availableKeywords
This publication has 469 references indexed in Scilit:
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumorsCancer Chemotherapy and Pharmacology, 2013
- The myofibroblast matrix: implications for tissue repair and fibrosisThe Journal of Pathology, 2012
- Differential macrophage programming in the tumor microenvironmentTrends in Immunology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid PThe International Journal of Biochemistry & Cell Biology, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Immunity, Inflammation, and CancerCell, 2010
- CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosisArthritis & Rheumatism, 2007
- Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycinThe International Journal of Biochemistry & Cell Biology, 2007
- The multistep nature of cancerTrends in Genetics, 1993